White Owl Capital Partners

White Owl Capital Partners is a venture capital firm founded in 2007 and based in New York, New York. The firm specializes in early-stage investments, primarily focusing on the technology and energy sectors. White Owl Capital Partners typically invests between $500,000 and $3 million in technology companies and between $5 million and $20 million in energy ventures. The firm's investment strategy reflects a commitment to fostering innovation and growth within these dynamic industries.

David Mars

Partner

14 past transactions

Brim Financial

Series B in 2021
Brim Financial Inc. is a Toronto-based company specializing in the issuance of non-banking credit cards, including reward, travel, and custom credit cards. Founded in 2015 and previously known as KREDITShare Inc., Brim Financial aims to enhance users' payment experiences through its innovative digital platform. This platform features embedded plans, custom security options, unlimited rewards, and digital installment plans. Additionally, it offers monetary advisory services through a real-time in-app portal, facilitating a seamless financial experience for customers and enabling them to efficiently redeem points against purchases.

BESE

Venture Round in 2020
BESE Inc is a digital media company based in Los Angeles, California, founded in 2017. It operates a platform dedicated to creating and distributing multi-format cultural storytelling aimed at millennial and Gen-Z audiences. The company focuses on providing digital news content and sharing untold stories from various cultures and nations. By leveraging social and digital platforms, BESE enables users to access information seamlessly and share their personal experiences, thereby broadening and reshaping the cultural narrative.

Lola Lola

Venture Round in 2018
Lola Lola operates as cannabis company. They serves to elevate the cannabis movement by creativity, connectivity, and community. They make all of their products as ethically and sustainably as possible, and to infuse every bud with heart-centered intentions.

TurnCare

Series A in 2017
TurnCare, Inc. specializes in manufacturing a pressure injury mitigation system aimed at preventing pressure ulcers in mobility-impaired patients. Founded in 2011 and based in Palo Alto, California, the company offers the Q2 System, which is designed to enhance perfusion by monitoring chamber pressures and adjusting the application of pressure to create non-alternating spaces. This innovative technology responds to patient movement and helps diminish perfusion issues caused by pressure-induced capillary compression. TurnCare is committed to improving patient care and recovery, focusing on high-acuity individuals by providing a cost-effective and user-friendly solution that facilitates healing and reduces pain.

Velano Vascular

Series B in 2017
Velano Vascular, Inc. is a medical device company based in San Francisco, California, established in 2011. The company specializes in the development of needle-free vascular access devices, particularly its FDA-approved PIVO device. This innovative, single-use, and sterile device allows for blood collection from indwelling peripheral IV lines, significantly reducing the need for traditional needle sticks and central line access. Velano Vascular aims to enhance patient care by providing a painless and efficient blood draw option, thereby improving the experience for hospital inpatients while also offering a safer practice for healthcare providers. Additionally, the PIVO device presents a financially responsible alternative for health systems, addressing the challenges associated with conventional vascular access methods.

Mass Appeal

Series A in 2017
Mass Appeal Media, Inc. is a multifaceted media company that produces and develops documentaries, scripted series, and unscripted formats for the film and television industry. Founded in 1996 and headquartered in New York, it has evolved from its origins as a graffiti magazine into a prominent publisher of urban lifestyle content. The company creates and publishes music, digital video, and editorial content, while also specializing in the production of premium advertising and branded content. Mass Appeal designs and executes marketing campaigns for global brands, reflecting a rich cultural heritage that spans music, art, and fashion. Its unique perspective aims to document the cultural convergence of these elements, engaging opinion leaders and trendsetters in contemporary conversations.

AdvisorConnect

Venture Round in 2017
AdvisorConnect is a sales acceleration platform designed to assist financial advisors and insurance agents in client acquisition and business development. The platform employs an AI-driven Network Navigator, which helps advisors identify potential clients by analyzing data from various social media, email accounts, and mobile devices. By consolidating this information, AdvisorConnect enables users to discover suitable markets and prospects embedded within their existing social networks. Additionally, the platform automates workflows and provides real-time, network-based analytics, allowing advisors to enhance their product, marketing, and content strategies effectively. Through these features, AdvisorConnect aims to streamline the process of finding new clients and improve the overall efficiency of advisors' operations.

DotAlign

Seed Round in 2016
DotAlign, Inc. is a New York-based company that provides a relationship intelligence and inbox productivity platform tailored for corporate environments, particularly investment banks and private equity firms. The platform enhances productivity by automatically extracting insights from various data sources, including email, calendars, contacts, and CRM systems. It assesses the strength of relationships within the organization, helping users identify key contacts, track communication, and understand who can facilitate important introductions. By analyzing this data in situ, DotAlign addresses compliance and privacy concerns while delivering actionable insights that support informed decision-making and foster business growth. Originally founded as OpSpark Inc. in 2009, the company rebranded to DotAlign in June 2012.

dosist

Seed Round in 2016
Dosist is a health and wellness company specializing in cannabis-based therapies delivered through proprietary vaporizing dose-pens. Founded in 2016 in California, originally named "hmbldt," the company emphasizes precise dosage to ensure safe and effective use of its products, which are intended for adults aged 21 and older. Dosist's innovative dose-controlled technology allows users to experience the benefits of cannabinoid-based therapy in a consistent and predictable manner. The company has gained recognition for its contributions to the industry, being named one of TIME Magazine's Top 25 Inventions of 2016 and a finalist for Fast Company's World Changing Ideas Awards. With a focus on dosage, Dosist aims to redefine the cannabis experience for consumers seeking natural plant-based therapies.

Vigilant Biosciences

Series B in 2016
Vigilant Biosciences, Inc. is a medical technology company focused on the early detection and intervention of oral cancer. Founded in 2011 and based in Fort Lauderdale, Florida, the company has developed non-invasive screening tests that utilize patented technology to measure specific biomarkers associated with oral cancer. Their product line, which includes the OncAlert Oral Cancer RAPID Test and the OncAlert Labs OraMark Test, employs a simple oral rinse procedure that is easy for healthcare practitioners to administer. These tests are designed to provide accurate and cost-effective results, allowing for timely medical intervention before visual or physical symptoms arise. The OncAlert product line is clinically validated and has received CE Mark certification for markets outside the United States, with plans for wider availability through a CLIA certified laboratory in the U.S.

Velano Vascular

Series A in 2016
Velano Vascular, Inc. is a medical device company based in San Francisco, California, established in 2011. The company specializes in the development of needle-free vascular access devices, particularly its FDA-approved PIVO device. This innovative, single-use, and sterile device allows for blood collection from indwelling peripheral IV lines, significantly reducing the need for traditional needle sticks and central line access. Velano Vascular aims to enhance patient care by providing a painless and efficient blood draw option, thereby improving the experience for hospital inpatients while also offering a safer practice for healthcare providers. Additionally, the PIVO device presents a financially responsible alternative for health systems, addressing the challenges associated with conventional vascular access methods.

Vigilant Biosciences

Series B in 2015
Vigilant Biosciences, Inc. is a medical technology company focused on the early detection and intervention of oral cancer. Founded in 2011 and based in Fort Lauderdale, Florida, the company has developed non-invasive screening tests that utilize patented technology to measure specific biomarkers associated with oral cancer. Their product line, which includes the OncAlert Oral Cancer RAPID Test and the OncAlert Labs OraMark Test, employs a simple oral rinse procedure that is easy for healthcare practitioners to administer. These tests are designed to provide accurate and cost-effective results, allowing for timely medical intervention before visual or physical symptoms arise. The OncAlert product line is clinically validated and has received CE Mark certification for markets outside the United States, with plans for wider availability through a CLIA certified laboratory in the U.S.

Velano Vascular

Series A in 2015
Velano Vascular, Inc. is a medical device company based in San Francisco, California, established in 2011. The company specializes in the development of needle-free vascular access devices, particularly its FDA-approved PIVO device. This innovative, single-use, and sterile device allows for blood collection from indwelling peripheral IV lines, significantly reducing the need for traditional needle sticks and central line access. Velano Vascular aims to enhance patient care by providing a painless and efficient blood draw option, thereby improving the experience for hospital inpatients while also offering a safer practice for healthcare providers. Additionally, the PIVO device presents a financially responsible alternative for health systems, addressing the challenges associated with conventional vascular access methods.

Mass Appeal

Seed Round in 2013
Mass Appeal Media, Inc. is a multifaceted media company that produces and develops documentaries, scripted series, and unscripted formats for the film and television industry. Founded in 1996 and headquartered in New York, it has evolved from its origins as a graffiti magazine into a prominent publisher of urban lifestyle content. The company creates and publishes music, digital video, and editorial content, while also specializing in the production of premium advertising and branded content. Mass Appeal designs and executes marketing campaigns for global brands, reflecting a rich cultural heritage that spans music, art, and fashion. Its unique perspective aims to document the cultural convergence of these elements, engaging opinion leaders and trendsetters in contemporary conversations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.